AI-Guided Discovery of Novel SARS-CoV-2 PLpro Inhibitors: Accelerating Antiviral Drug Development in the Fight Against COVID-19
This study uses AI-driven drug discovery to identify novel SARS-CoV-2 PLpro inhibitors, including CSEMRS-1376, with favorable ADMET profiles and strong binding affinity.
bioRxiv · Apr 5, 2023 · PreprintPharmacology & Toxicology